Any stock, in context
BAFNAPH · Healthcare
Bafna Pharmaceuticals Limited
Observation · 15 Oct 2026
How these are readBafna Pharmaceuticals closed at ₹452.4 on 15 Oct 2026, 137.1% above its 200-day average and 43.0% above its 50-day average: above both lines. It sits 0.0% below its highest close of the past year, in the top fifth of its one-year range. Over three months it rose 100.3%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- New 52-week high this week
- Meets the leaders screen
- Trade-for-trade (BE series)
- Thinly traded: under ₹1 crore a day
- vs 200-day
- +137.1%
- the long line
- vs 50-day
- +43.0%
- the short line
- From 52w high
- 0.0%
- ₹94.77₹452.4
- 3 months
- +100.3%
- sector median −2.7% · 3 of 146
Listed outside the Nifty indices · Healthcare (sector mapped from its industry) · BE series (trade-for-trade) · median traded value ₹0.13 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- +2.00%
- 1W
- –
- 1M
- +47.20%
- 3M
- +100.26%
- YTD
- –
- 1Y
- +201.89%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.